Paper623398
Theophylline bioavailability following oral administration of six sustained-release preparations.
Spangler DL and 3 others. Ann Allergy, 1978. Cited by 127 papers, by iCite.
Cite this record
ConductScience Library. Theophylline bioavailability following oral administration of six sustained-release preparations. Papers, record 623398. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/623398
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Theophylline bioavailability following oral administration of six sustained-release preparations.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Theophylline | Major topic |
| Administration, Oral | |
| Adult | |
| Biological Availability | |
| Delayed-Action Preparations | |
| Drug Evaluation | |
| Humans | |
| Male | |
| Middle Aged | |
| Nausea | |
| Tachycardia, Paroxysmal | |
| Tremor |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 127 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8005187 | Kinetic interaction between theophylline and a newly developed anti-allergic drug, pemirolast potassium. | Eur J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/8005187 | PubMed |
| 7431220 | Evaluation of the absorption from some commercial enteric-release theophylline products. | J Pharmacokinet Biopharm | 1980 | https://conductscience.org/library/papers/7431220 | PubMed |
| 7431219 | Evaluation of the absorption from some commercial sustained-release theophylline products. | J Pharmacokinet Biopharm | 1980 | https://conductscience.org/library/papers/7431219 | PubMed |
| 7420268 | Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria. | J Pharmacokinet Biopharm | 1980 | https://conductscience.org/library/papers/7420268 | PubMed |
| 7042294 | Rate-controlled drug dosage. | Drugs | 1982 | https://conductscience.org/library/papers/7042294 | PubMed |
| 6866717 | In vitro testing of controlled release theophylline preparations: Theolair, Theograd and Theolin. | Pharm Weekbl Sci | 1983 | https://conductscience.org/library/papers/6866717 | PubMed |
| 6840168 | Sustained serum theophylline concentrations during chronic twice daily administration of a slow release preparation. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6840168 | PubMed |
| 6832206 | Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6832206 | PubMed |
| 6783231 | Combined treatment with sustained-release theophylline and beta2-adrenoceptor-stimulating agents in chronic childhood asthma. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6783231 | PubMed |
| 6760111 | A double-blind comparative trial between two sustained-release theophylline preparations with individual doses in asthmatic in-patients. | Pharm Weekbl Sci | 1982 | https://conductscience.org/library/papers/6760111 | PubMed |
| 6734702 | Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6734702 | PubMed |
| 6686557 | Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6686557 | PubMed |
| 6439357 | Slow release theophyllines and chronic bronchitis. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6439357 | PubMed |
| 6370542 | A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6370542 | PubMed |
| 6131723 | New drugs in respiratory disorders: I. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6131723 | PubMed |
| 3982951 | Food and a sustained release theophylline tablet on chronic dosing: bioavailability, peak-trough and trough-trough differences. | Pharm Weekbl Sci | 1985 | https://conductscience.org/library/papers/3982951 | PubMed |
| 3834072 | New method for bioavailability assessment of slow-release preparations of theophylline. | J Pharmacokinet Biopharm | 1985 | https://conductscience.org/library/papers/3834072 | PubMed |
| 3790407 | The effect of age on theophylline clearance in normal subjects. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3790407 | PubMed |
| 3508547 | Computer-aided dosage form design. II. Methods for defining a zero-order sustained-release delivery system of maximum formulating flexibility. | Pharm Res | 1987 | https://conductscience.org/library/papers/3508547 | PubMed |
| 3315687 | A once daily theophylline preparation in prevention of nocturnal symptoms in childhood asthma. | Eur J Pediatr | 1987 | https://conductscience.org/library/papers/3315687 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/623398
GET https://conductscience.org/api/papers/v1/623398/cited_by?page=2